{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:39:32Z","timestamp":1793367572430,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203305"],"award-info":[{"award-number":["82203305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20274"],"award-info":[{"award-number":["U22A20274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2304800"],"award-info":[{"award-number":["2022YFC2304800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.apsb.2025.01.017","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T19:25:38Z","timestamp":1738092338000},"page":"1383-1396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis"],"prefix":"10.1016","volume":"15","author":[{"given":"Kaifeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0862-3291","authenticated-orcid":false,"given":"Xieer","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5320-227X","authenticated-orcid":false,"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.01.017_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.01.017_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2025.01.017_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2025.01.017_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.01.017_bib5","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice","volume":"13","author":"Singal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2025.01.017_bib6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2025.01.017_bib7","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.apsb.2024.03.025","article-title":"Gut commensal metabolite rhamnose promotes macrophages phagocytosis by activating SLC12A4 and protects against sepsis in mice","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.01.017_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","article-title":"Identification of bioactive metabolites using activity metabolomics","volume":"20","author":"Rinschen","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2025.01.017_bib9","article-title":"Metabolite sensing and signaling in cell metabolism","volume":"3","author":"Wang","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.01.017_bib10","article-title":"Signaling pathways in cancer metabolism: mechanisms and therapeutic targets","volume":"8","author":"You","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.01.017_bib11","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.apsb.2023.07.011","article-title":"Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.01.017_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2630-0","article-title":"Age-induced accumulation of methylmalonic acid promotes tumour progression","volume":"585","author":"Gomes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.01.017_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/ajcn\/nqy074","article-title":"Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort","volume":"108","author":"Assi","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.apsb.2025.01.017_bib14","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/ijc.34229","article-title":"Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: a prospective study in two Chinese cohorts","volume":"151","author":"Hang","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2025.01.017_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/ijc.33885","article-title":"Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma","volume":"150","author":"Stepien","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2025.01.017_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04801-4","article-title":"Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients","volume":"21","author":"Caponigro","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.apsb.2025.01.017_bib17","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1021\/ac4016787","article-title":"Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography\/triple quadrupole mass spectrometry","volume":"85","author":"Chen","year":"2013","journal-title":"Anal Chem"},{"key":"10.1016\/j.apsb.2025.01.017_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/1940-6207.CAPR-17-0249","article-title":"Metabolomics profiles of hepatocellular carcinoma in a Korean prospective cohort: the Korean cancer prevention study-II","volume":"11","author":"Jee","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.apsb.2025.01.017_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1158\/0008-5472.CAN-22-2273","article-title":"Long-chain acylcarnitines induce senescence of invariant natural killer T cells in hepatocellular carcinoma","volume":"83","author":"Cheng","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.01.017_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41380-018-0047-z","article-title":"Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents","volume":"24","author":"Zhou","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.apsb.2025.01.017_bib21","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1021\/acs.analchem.0c04686","article-title":"A metabolite array technology for precision medicine","volume":"93","author":"Xie","year":"2021","journal-title":"Anal Chem"},{"key":"10.1016\/j.apsb.2025.01.017_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT\u2013mTORC1\u2013RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2025.01.017_bib23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hep.22169","article-title":"Integration of genomic analysis and in\u00a0vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.01.017_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.08.006","article-title":"Global analysis of plasma lipids identifies liver-derived acylcarnitines as a fuel source for brown fat thermogenesis","volume":"26","author":"Simcox","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.01.017_bib25","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1039\/C6AN01753C","article-title":"Strategies for large-scale targeted metabolomics quantification by liquid chromatography\u2013mass spectrometry","volume":"141","author":"Zhou","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.apsb.2025.01.017_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.gastro.2021.10.015","article-title":"MicroRNA-15a\/16-1 prevents hepatocellular carcinoma by disrupting the communication between kupffer cells and regulatory T cells","volume":"162","author":"Liu","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2025.01.017_bib27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.01.017_bib28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2019.07.028","article-title":"An immune gene expression signature associated with development of human hepatocellular carcinoma identifies mice that respond to chemopreventive agents","volume":"157","author":"Moeini","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2025.01.017_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.physiol.64.082201.154705","article-title":"Fatty acid oxidation disorders","volume":"64","author":"Rinaldo","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.apsb.2025.01.017_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31466-2","article-title":"Structural basis for defective membrane targeting of mutant enzyme in human VLCAD deficiency","volume":"13","author":"Prew","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.01.017_bib31","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41418-020-0491-6","article-title":"Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD\/NASH","volume":"27","author":"Tan","year":"2020","journal-title":"Cell Death Differ"},{"issue":"Pt 1","key":"10.1016\/j.apsb.2025.01.017_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/bj3340113","article-title":"The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076","volume":"334","author":"Pearce","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2025.01.017_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","article-title":"ATP citrate lyase inhibition can suppress tumor cell growth","volume":"8","author":"Hatzivassiliou","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.01.017_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.01.017_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acsmedchemlett.5b00385","article-title":"Characterizing the covalent targets of a small molecule inhibitor of the lysine acetyltransferase P300","volume":"7","author":"Shrimp","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2025.01.017_bib36","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.02.015","article-title":"P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts","volume":"154","author":"Dou","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2025.01.017_bib37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cac2.12155","article-title":"Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6\/E2F1 positive feedback loop in lung adenocarcinoma","volume":"41","author":"Zhang","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.apsb.2025.01.017_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12635","article-title":"MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204\/miR-191\/KLF6 axis","volume":"52","author":"Tian","year":"2019","journal-title":"Cell Prolif"},{"key":"10.1016\/j.apsb.2025.01.017_bib39","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jhep.2010.04.038","article-title":"The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions","volume":"53","author":"Hanoun","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2025.01.017_bib40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/hep.25810","article-title":"Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing","volume":"56","author":"Vetter","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.01.017_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.01.017_bib42","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2025.01.017_bib43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.1840030413","article-title":"Elevated plasma carnitine in hepatic cirrhosis","volume":"3","author":"Fuller","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.01.017_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/hep.510250127","article-title":"Carnitine metabolism in patients with chronic liver disease","volume":"25","author":"Krahenbuhl","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.01.017_bib45","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00319.2019","article-title":"The fatty acid derivative palmitoylcarnitine abrogates colorectal cancer cell survival by depleting glutathione","volume":"317","author":"Turnbull","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2025.01.017_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-018-9448-1","article-title":"Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle","volume":"19","author":"Knottnerus","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.apsb.2025.01.017_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2014old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2025.01.017_bib48","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","article-title":"CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity","volume":"67","author":"Fujiwara","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2025.01.017_bib49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","article-title":"Acetyl coenzyme A: a central metabolite and second messenger","volume":"21","author":"Pietrocola","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.01.017_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","article-title":"Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation","volume":"20","author":"Lee","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.01.017_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.molcel.2011.05.004","article-title":"Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes","volume":"42","author":"Cai","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2025.01.017_bib52","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.celrep.2016.10.012","article-title":"Lipids reprogram metabolism to become a major carbon source for histone acetylation","volume":"17","author":"McDonnell","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.01.017_bib53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.45.120403.095832","article-title":"Aberrant DNA methylation as a cancer-inducing mechanism","volume":"45","author":"Esteller","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2025.01.017_bib54","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1126\/science.1066326","article-title":"KLF6, a candidate tumor suppressor gene mutated in prostate cancer","volume":"294","author":"Narla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.01.017_bib55","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2004.01.005","article-title":"Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer","volume":"126","author":"Reeves","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2025.01.017_bib56","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ijc.11123","article-title":"KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas","volume":"105","author":"Jeng","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2025.01.017_bib57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2006.10.012","article-title":"Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation","volume":"46","author":"Kremer-Tal","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2025.01.017_bib58","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.20460","article-title":"Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma","volume":"40","author":"Kremer-Tal","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.01.017_bib59","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbalip.2014.04.001","article-title":"Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism","volume":"1841","author":"Schooneman","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2025.01.017_bib60","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.clnu.2016.08.019","article-title":"Palmitoyl-carnitine production by blood cells associates with the concentration of circulating acyl-carnitines in healthy overweight women","volume":"36","author":"Chondronikola","year":"2017","journal-title":"Clin Nutr"}],"updated-by":[{"DOI":"10.1016\/j.apsb.2026.08.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000}},{"DOI":"10.1016\/j.apsb.2026.08.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:17:25Z","timestamp":1762604245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2211383525000231"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.01.017","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}